Table 3 Non-responder analysis: Descriptive results and prevalence of atopic diseases, data taken from ISAAC Phase Two.
From: Study on Occupational Allergy Risks (SOLAR II) in Germany: Design and methods
% 95% CI1 | Group 12 (n = 2581) | Group 23 (n = 1767) | Group 34 (n = 2051) |
|---|---|---|---|
Female | 55.0 53.1; 56.9 | 53.8 51.5; 56.1 | 58.1 56.0; 60.3 |
High parental level of education5 | 41.5 39.5; 43.5 | 47.1 44.7; 49.4 | 58.9 56.7; 61.0 |
Smoking during pregnancy | 13.5 11.9; 15.1 | 9.8 8.3; 11.4 | 5.9 4.8; 7.0 |
Passive smoke exposure | 50.3 48.3; 52.4 | 47.3 44.9; 49.7 | 36.4 34.3; 38.5 |
Current wheeze6 | 6.9 5.9; 7.9 | 9.5 8.1; 10.8 | 8.2 7.0; 9.4 |
Doctor diagnosed asthma | 3.3 2.6; 4.0 | 4.5 3.5; 5.5 | 3.4 2.6; 4.2 |
Current allergic rhinitis7 | 11.1 9.8; 12.3 | 14.1 12.4; 15.7 | 14.4 12.8; 15.9 |
Current atopic dermatitis8 | 11.6 10.4; 12.9 | 13.2 11.6; 14.8 | 15.2 13.6; 16.7 |
Specific IgE > 0.7 kU/L | 28.7 26.0; 31.3 | 34.8 32.1; 37.4 | 33.4 31.0; 35.7 |
Positive skin prick test | 23.2 21.0; 25.5 | 24.5 22.3; 26.7 | 23.6 21.7; 25.6 |
Bronchial hyperreactivity | 14.7 11.9; 17.4 | 19.5 16.5; 22.4 | 17.3 14.8; 19.8 |
Parental allergic disease9 | 36.2 34.3; 38.1 | 40.9 38.6; 43.3 | 46.2 44.0; 48.3 |